Riskpilot← Back to searchSign inGet full accessImmedica Pharma Holding AB
ABDissolvedOrg 5591479554Activities of holding companies · NACE 6421Est. 20180 employees
Revenue 2024
SEK 0
EBITDA margin
—
-757% vs 2023
Equity ratio
95.6%
Financial strength
Net profit 2024
SEK -16,5M
-4029% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -15,7M | -757% |
| Net profit | SEK -16,5M | -4029% |
| Total assets | SEK 942,1M | +18% |
| Equity | SEK 900,5M | +17% |
| Employees | 0 | — |
Legal name
Immedica Pharma Holding AB
Org number
5591479554
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
2 februari 2018
Share capital
SEK 269 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet ska vara att investera i bolag fokuserade på friskvård och hälsorelaterad verksamhet, äga, förvalta och utveckla verksamheten i denna typ av bolag, samt därmed förenlig verksamhet.
Address
Email
legal@immedica.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 582 | −1 970 | −2 206 | −1 832 | −15 692 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 582 | −1 970 | −2 206 | −1 832 | −15 692 |
| Net financials | −180 | −51 | 26 | 192 | 9 |
| Profit before tax | 0 | 147 | −2 175 | −1 640 | −15 577 |
| Tax | −0 | −0 | −0 | 2 061 | −963 |
| Net profit | 0 | 147 | −2 175 | 421 | −16 540 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 278 693 | 483 332 | 666 693 | 796 358 | 942 086 |
| Equity | 278 131 | 483 266 | 644 212 | 771 999 | 900 461 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 562 | 65 | 22 481 | 24 359 | 41 626 |
| Total debt | 562 | 65 | 22 481 | 24 359 | 41 626 |
EBITDA margin
-1569200000.0%
This company
15.8%
Market median
-9931645670% vs market
20202024
Equity ratio
95.6%
This company
38.2%
Market median
+150% vs market
20202024
Return on equity
-1.8%
This company
18.4%
Market median
-110% vs market
20202024
Net profit margin
-1654000000.0%
This company
8.1%
Market median
-20419753186% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
PJ Chief Auditor | Chief Auditor | 2020 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Former (9) | ||
| Board of Directors | 2020 – 2024 | |
| Deputy Board Member | 2020 – 2024 | |
| Board of Directors | 2020 – 2024 | |
| Chairman | 2020 – 2020 | |
| Board of Directors | 2021 – 2024 | |
| Chairman | 2020 – 2024 | |
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2021 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Immedica TopCo ABImmedica MidCo ABImmedica Bidco AB
Immedica Pharma Holding AB (this company)Immedica Specialty Care Ro S.R.L.Immedica Pharma France SarlImmedica Pharma Iberia SlImmedica Pharma Middle East Fz-LlcIMMEDICA SPECIALTY CARE RO S.R.L.IMMEDICA PHARMA US INCIMMEDICA PHARMA POLSKA SP. Z O OImmedica Pharma Polska Sp. Z O oImmedica Pharma Germany GmbhImmedica Pharma Polska Sp. z o oImmedica Pharma Italy S.R.lImmedica Pharma Uk LtdImmedica Pharma Cee, S.R.O.IMMEDICA PHARMA ITALY S.R.LIMMEDICA PHARMA CEE, S.R.O.IMMEDICA PHARMA UK LTDIMMEDICA PHARMA GERMANY GMBHIMMEDICA PHARMA IBERIA SLIMMEDICA PHARMA FRANCE SARLIMMEDICA PHARMA MIDDLE EAST FZ-LLCBoard members of Immedica Pharma Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Johan Engstam | Chief Auditor | 0 companies |
| Kerstin B Valinder Strinnholm | Board of Directors | 0 companies |
| Johan Fredrik Odin | Deputy Board Member | 0 companies |
| Peder Sven Walberg | Board of Directors | 0 companies |
| Simon Petter Falk | Board of Directors | 0 companies |
| Johan Fredrik Strömholm | Chairman | 0 companies |
| Per Anders Edvell | Chairman | 0 companies |
| Carl Holger Stefan Larsson | Board of Directors | 0 companies |
| Thomas Lennart Eklund | Chairman | 0 companies |
| Tor Simon Angeldorff | Board of Directors | 0 companies |
| Carl Magnus Edlund | Board of Directors | 0 companies |
| Lisa Jane Morrison | Board of Directors | 0 companies |
| Nina Magdalena Fleck | Board of Directors | 0 companies |